Future Market Insights
African Horse Sickness (AHS) is an acute or mild infection which is non-contagious disease, primarily affecting equine species. The disease is spread by a virus African Horse Sickness Virus (AFSV). African Horse Sickness can cause a mortality rate as high as 95 percent in horses, which are most susceptible to the disease, while mules are less likely, and donkeys are exceptions to African Horse Sickness Disease. A preventive method for African horse sickness treatment is good vaccination program, apart from a good nutritional program and regular deworming which forms an integral part of horse health. Prevention programs are an efficient method and cost effective way to prevent common infectious diseases in a horse.
African Horse Sickness Treatment Market: Segmentation
African horse sickness disease is found in four clinical forms and the diagnosis and disease symptoms varied from one form to another. On the basis of various clinical forms of the disease, we can segment the market into the following:
Pulmonary Form or “Dunkop”
Cardiac Form or “Dikkop”
Horse Sickness Fever
On the basis of diagnosis of the disease and prevention strategies, we can segment the African horse sickness market into:
Laboratory Tests for Viral Antigens
Enzyme-linked Immunosorbent Assays (ELISA)
Reverse-transcription PCR assays
Currently, there is no specific therapy for the treatment of African horse treatment disease and prevention of horses from the disease is recommended. The treatment for African horse sickness is recommended from supportive treatment therapy.
African Horse Sickness Treatment Market: Dynamics
African horse sickness treatment (AHS) market is a growing market for various preventive vaccines in research and development. Additionally, the multivalent, modified-live vaccine does not guarantee the protection of horses from African horse sickness and only decreases the probability of a horse getting the disease.
African Horse Sickness Treatment Market: Region-wise Outlook
Based on geography, the African horse sickness treatment market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the African horse sickness treatment market followed by Europe. The major driving factors which have driven the growth of the African horse sickness treatment market in these regions are the presence of guidelines and standard operating procedures for African horse sickness disease. In U.S.A., organizations such as United States Department of Agriculture (USDA), issues standard operating procedures for the African horse sickness disease. Following North America, European countries are also anticipated to show steady growth in the African horse sickness treatment market. In the next few years, Asia-Pacific would show remarkable growth in the African horse sickness treatment market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors which would fuel the growth of African horse sickness treatment market in Asia-Pacific are increasing awareness regarding vaccination of horses, rising healthcare infrastructure, and rapid development of the healthcare infrastructure across the Asian countries. African horse sickness treatment market would evolve at a rapid rate across the regions. However, North America would maintain its position in the overall African horse sickness treatment market.
African Horse Sickness Treatment Market: Key Players
It is expected that with due course of time, there will be an influx of well-established players in the African horse sickness treatment market. One of the top players operating in the African horse sickness treatment market is Onderstepoort Biological Products SOC Ltd which manufactures polyvalent African horse sickness vaccine and is licensed in South Africa. Various institutes are manufacturing vaccine for African horse sickness treatment such as Veterinary Serum and Vaccine Research Institute which is based out in Egypt is manufacturing Bivalent Adjuvant Inactivated African Horse Sickness Vaccine for Type 4, 9 strain. African horse sickness treatment market has a presence of many regional players and research institutes manufacturing vaccines which have a huge market share in emerging countries
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.